On January 2, 2019 Alexion Pharmaceuticals (Nasdaq: ALXN) reported that management will present at the (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437])9 at 7:30 a.m., PT (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437]). A breakout question and answer session will immediately follow the formal presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Audio webcasts of the presentation and breakout question and answer session will be available live. You can access the webcasts at: View Source An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

On January 2, 2019 LabCorp (NYSE: LH) reported it will participate at the 37th Annual J.P. Morgan Healthcare Conference (Press release, LabCorp, JAN 2, 2019, View Source;p=RssLanding&cat=news&id=2381927 [SID1234532436]). LabCorp’s presentation is scheduled for Tuesday, January 8, 2019 at 1:30 p.m. (PT), followed by a question and answer session at 2:00 p.m. (PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation and the subsequent question and answer session will be available via the Company website at www.labcorp.com and archived for replay.

On January 2, 2019 Novavax, Inc. (Nasdaq:NVAX) reported that it will present at the 37th Annual J.P. Morgan Healthcare Conference (Press release, Novavax, JAN 2, 2019, View Source [SID1234532400]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Date and time:Wednesday, January 9, 3:00 p.m. – 3:25 p.m. P.T.
Location:Colonial Room, Westin St. Francis Hotel, San Francisco
Live webcast:www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section of the website at www.novavax.com.

On January 2, 2019 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported that management will present at the J.P. Morgan Healthcare Conference onMonday, January 7, 2019 at 2:30 p.m. ET (11:30 a.m. PT) (Press release, Vertex Pharmaceuticals, JAN 2, 2019, View Source [SID1234532399]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company’s website.

On January 2, 2019 Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, reported that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco (Press release, Quest Diagnostics, JAN 2, 2019, View Source [SID1234532395]). Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company’s vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 8, 2019 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guinan also will participate in a Q&A session moderated by the host analyst.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation and Q&A session will be webcast live during the conference and will be available on the company’s investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 7, 2019.